ETOROOT-TH4

Product Introduction ETOROOT-TH4

Etoricoxib

Etoricoxib is a new COX-2 selective inhibitor. Current therapeutic indications are: treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, chronic low back pain, acute pain and gout. Like any other COX-2 selective inhibitor, Etoricoxib selectively inhibits isoform 2 of cyclo-oxigenase enzyme (COX-2). This reduces the generation of prostaglandins (PGs) from arachidonic acid.

Thiocolchicoside

Thiocolchicoside is a muscle relaxant with anti-inflammatory and analgesic effects. Thiocolchicoside acts as a competitive GABAA receptor antagonist and also glycine receptor antagonist with similar potency and nicotinic acetylcholine receptors to a much lesser extent. Thiocolchicoside has powerful convulsant activity and should not be used in seizure-prone individuals.Indication of ETOROOT-P

Indications ETOROOT-TH4

• Etoricoxib a selective COX-2 inhibitor which helps to reduce the pain and swelling (inflammation) in the joints and muscles of people 16 years of age and older with osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and gout.
• For the treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, chronic low back pain, acute pain and gout.
• For the treatment of muscle spasms.

Side Effects

Common side effects are Flu-like symptoms, Indigestion, Stomach pain, Diarrhea, Peripheral edema and Flatulence.